Cargando…
High bone mass in mice can be linked to lower osteoclast formation, resorptive capacity, and restricted in vitro sensitivity to inhibition by stable sulforaphane
Mouse strains can have divergent basal bone mass, yet this phenotype is seldom reflected in the design of studies seeking to identify new modulators of bone resorption by osteoclasts. Sulforaphane exerts inhibitory effects on in vitro osteoclastogenesis in cells from C57BL/6 mice. Here, we explore w...
Autores principales: | Louka, Polymnia, Orriss, Isabel R., Pitsillides, Andrew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804804/ https://www.ncbi.nlm.nih.gov/pubmed/35924674 http://dx.doi.org/10.1002/cbf.3734 |
Ejemplares similares
-
Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis
por: Javaheri, Behzad, et al.
Publicado: (2017) -
Human osteoclast formation and resorptive function on biomineralized collagen
por: de Melo Pereira, Daniel, et al.
Publicado: (2021) -
Osteoclast-derived SLIT3 is a coupling factor linking bone resorption to bone formation
por: Koh, Jung-Min
Publicado: (2018) -
Osteoclastic resorptive capacity is suppressed in patients receiving hyperbaric oxygen therapy
por: Hadi, Hadil Al, et al.
Publicado: (2015) -
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
por: Kitaura, Hideki, et al.
Publicado: (2020)